305 related articles for article (PubMed ID: 17484760)
1. The natural history and treatment of epilepsy in a murine model of tuberous sclerosis.
Erbayat-Altay E; Zeng LH; Xu L; Gutmann DH; Wong M
Epilepsia; 2007 Aug; 48(8):1470-6. PubMed ID: 17484760
[TBL] [Abstract][Full Text] [Related]
2. Rapamycin prevents epilepsy in a mouse model of tuberous sclerosis complex.
Zeng LH; Xu L; Gutmann DH; Wong M
Ann Neurol; 2008 Apr; 63(4):444-53. PubMed ID: 18389497
[TBL] [Abstract][Full Text] [Related]
3. Microglial activation during epileptogenesis in a mouse model of tuberous sclerosis complex.
Zhang B; Zou J; Han L; Rensing N; Wong M
Epilepsia; 2016 Aug; 57(8):1317-25. PubMed ID: 27263494
[TBL] [Abstract][Full Text] [Related]
4. Tsc2 gene inactivation causes a more severe epilepsy phenotype than Tsc1 inactivation in a mouse model of tuberous sclerosis complex.
Zeng LH; Rensing NR; Zhang B; Gutmann DH; Gambello MJ; Wong M
Hum Mol Genet; 2011 Feb; 20(3):445-54. PubMed ID: 21062901
[TBL] [Abstract][Full Text] [Related]
5. Early developmental electroencephalography abnormalities, neonatal seizures, and induced spasms in a mouse model of tuberous sclerosis complex.
Rensing N; Johnson KJ; Foutz TJ; Friedman JL; Galindo R; Wong M
Epilepsia; 2020 May; 61(5):879-891. PubMed ID: 32274803
[TBL] [Abstract][Full Text] [Related]
6. Epileptogenesis and reduced inward rectifier potassium current in tuberous sclerosis complex-1-deficient astrocytes.
Jansen LA; Uhlmann EJ; Crino PB; Gutmann DH; Wong M
Epilepsia; 2005 Dec; 46(12):1871-80. PubMed ID: 16393152
[TBL] [Abstract][Full Text] [Related]
7. Cerebral vascular and blood brain-barrier abnormalities in a mouse model of epilepsy and tuberous sclerosis complex.
Guo D; Zhang B; Han L; Rensing NR; Wong M
Epilepsia; 2024 Feb; 65(2):483-496. PubMed ID: 38049961
[TBL] [Abstract][Full Text] [Related]
8. Modulation of astrocyte glutamate transporters decreases seizures in a mouse model of Tuberous Sclerosis Complex.
Zeng LH; Bero AW; Zhang B; Holtzman DM; Wong M
Neurobiol Dis; 2010 Mar; 37(3):764-71. PubMed ID: 20045054
[TBL] [Abstract][Full Text] [Related]
9. Intermittent dosing of rapamycin maintains antiepileptogenic effects in a mouse model of tuberous sclerosis complex.
Rensing N; Han L; Wong M
Epilepsia; 2015 Jul; 56(7):1088-97. PubMed ID: 26122303
[TBL] [Abstract][Full Text] [Related]
10. Inflammatory mechanisms contribute to the neurological manifestations of tuberous sclerosis complex.
Zhang B; Zou J; Rensing NR; Yang M; Wong M
Neurobiol Dis; 2015 Aug; 80():70-9. PubMed ID: 26003087
[TBL] [Abstract][Full Text] [Related]
11. Postnatal reduction of tuberous sclerosis complex 1 expression in astrocytes and neurons causes seizures in an age-dependent manner.
Zou J; Zhang B; Gutmann DH; Wong M
Epilepsia; 2017 Dec; 58(12):2053-2063. PubMed ID: 29023667
[TBL] [Abstract][Full Text] [Related]
12. The specificity and role of microglia in epileptogenesis in mouse models of tuberous sclerosis complex.
Zhang B; Zou J; Han L; Beeler B; Friedman JL; Griffin E; Piao YS; Rensing NR; Wong M
Epilepsia; 2018 Sep; 59(9):1796-1806. PubMed ID: 30079598
[TBL] [Abstract][Full Text] [Related]
13. Impaired glial glutamate transport in a mouse tuberous sclerosis epilepsy model.
Wong M; Ess KC; Uhlmann EJ; Jansen LA; Li W; Crino PB; Mennerick S; Yamada KA; Gutmann DH
Ann Neurol; 2003 Aug; 54(2):251-6. PubMed ID: 12891680
[TBL] [Abstract][Full Text] [Related]
14. Epilepsy in young Tsc1(+/-) mice exhibits age-dependent expression that mimics that of human tuberous sclerosis complex.
Gataullina S; Lemaire E; Wendling F; Kaminska A; Watrin F; Riquet A; Ville D; Moutard ML; de Saint Martin A; Napuri S; Pedespan JM; Eisermann M; Bahi-Buisson N; Nabbout R; Chiron C; Dulac O; Huberfeld G
Epilepsia; 2016 Apr; 57(4):648-59. PubMed ID: 26873267
[TBL] [Abstract][Full Text] [Related]
15. Abnormal glutamate homeostasis and impaired synaptic plasticity and learning in a mouse model of tuberous sclerosis complex.
Zeng LH; Ouyang Y; Gazit V; Cirrito JR; Jansen LA; Ess KC; Yamada KA; Wozniak DF; Holtzman DM; Gutmann DH; Wong M
Neurobiol Dis; 2007 Nov; 28(2):184-96. PubMed ID: 17714952
[TBL] [Abstract][Full Text] [Related]
16. A circuitry and biochemical basis for tuberous sclerosis symptoms: from epilepsy to neurocognitive deficits.
Feliciano DM; Lin TV; Hartman NW; Bartley CM; Kubera C; Hsieh L; Lafourcade C; O'Keefe RA; Bordey A
Int J Dev Neurosci; 2013 Nov; 31(7):667-78. PubMed ID: 23485365
[TBL] [Abstract][Full Text] [Related]
17. Impaired astrocytic gap junction coupling and potassium buffering in a mouse model of tuberous sclerosis complex.
Xu L; Zeng LH; Wong M
Neurobiol Dis; 2009 May; 34(2):291-9. PubMed ID: 19385061
[TBL] [Abstract][Full Text] [Related]
18. Early epileptiform EEG activity in infants with tuberous sclerosis complex predicts epilepsy and neurodevelopmental outcomes.
De Ridder J; Verhelle B; Vervisch J; Lemmens K; Kotulska K; Moavero R; Curatolo P; Weschke B; Riney K; Feucht M; Krsek P; Nabbout R; Jansen AC; Wojdan K; Domanska-Pakieła D; Kaczorowska-Frontczak M; Hertzberg C; Ferrier CH; Samueli S; Benova B; Aronica E; Kwiatkowski DJ; Jansen FE; Jóźwiak S; Lagae L;
Epilepsia; 2021 May; 62(5):1208-1219. PubMed ID: 33778971
[TBL] [Abstract][Full Text] [Related]
19. Everolimus in tuberous sclerosis patients with intractable epilepsy: a treatment option?
Wiegand G; May TW; Ostertag P; Boor R; Stephani U; Franz DN
Eur J Paediatr Neurol; 2013 Nov; 17(6):631-8. PubMed ID: 23845174
[TBL] [Abstract][Full Text] [Related]
20. Hypothalamic orexin and mechanistic target of rapamycin activation mediate sleep dysfunction in a mouse model of tuberous sclerosis complex.
Zhang B; Guo D; Han L; Rensing N; Satoh A; Wong M
Neurobiol Dis; 2020 Feb; 134():104615. PubMed ID: 31605778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
